Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | GRM5 | P41594 | 2/20 | 0.44 |
| ▸ | MAPK9 | P45984 | 4/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.41 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.41 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.41 |
| ▸ | RAF1 | P04049 | 1/20 | 0.41 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.40 |
| ▸ | CCNT1 | O60563 | 2/20 | 0.40 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.40 |
| ▸ | CDK2 | P24941 | 2/20 | 0.40 |
| ▸ | CDK9 | P50750 | 2/20 | 0.40 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.40 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.40 |
| ▸ | CDK5R1 | Q15078 | 2/20 | 0.40 |
| ▸ | LATS1 | O95835 | 1/20 | 0.40 |
| ▸ | LATS2 | Q9NRM7 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30595872 | 1.00 | HSP90AA1 (0.52) | HSP90AA1CYP2D6GRM5MAPK9MAPK14 | |
| SCHEMBL10402322 | 0.94 | HSP90AA1 (0.48) | HSP90AA1CYP2D6GRM5MAPK9MAPK14 | |
| SCHEMBL13910999 | 0.90 | HSP90AA1 (0.50) | HSP90AA1CYP2D6GRM5MAPK9MAPK14 | |
| SCHEMBL3107817 | 0.87 | LMNA (0.44) | HSP90AA1CYP2D6GRM5MAPK9MAPK14 | |
| SCHEMBL9903935 | 0.85 | CYP2D6 (0.60) | HSP90AA1CYP2D6GRM5MAPK9MAPK14 | |
| SCHEMBL4294864 | 0.84 | KDM4E (0.67) | HSP90AA1GRM5MAPK9MAPK14MAPK11 | |
| SCHEMBL29394083 | 0.84 | KDM4E (0.67) | HSP90AA1GRM5MAPK9MAPK14MAPK11 | |
| SCHEMBL25295479 | 0.83 | TP53 (0.48) | HSP90AA1CYP2D6GRM5MAPK9MAPK14 | |
| SCHEMBL5989213 | 0.83 | HSP90AA1 (0.44) | HSP90AA1CYP2D6GRM5MAPK9MAPK14 | |
| SCHEMBL8499115 | 0.83 | CYP2D6 (0.53) | HSP90AA1CYP2D6GRM5MAPK9MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120259073-A1 | METHODS FOR THE SYNTHESIS OF MODULAR POLY(PHENYLENEETHYNYLENES) AND FINE TUNING THE ELECTRONIC PROPERTIES THEREOF FOR THE FUNCTIONALIZATION OF NANOMATERIALS | ZYVEX PERFORMANCE MATERIALS, INC. (US) | 2012-10-11 | — | — | US | claimed |
| US-20100009165-A1 | Multifunctional Nanomaterial-Containing Composites and Methods for the Production Thereof | ZYVEX PERFORMANCE MATERIALS, LLC (US) | 2010-01-14 | — | — | US | claimed |
| US-20090203867-A1 | METHODS FOR THE SYNTHESIS OF MODULAR POLY(PHENYLENEETHYNYLENES) AND FINE TUNING THE ELECTRONIC PROPERTIES THEREOF FOR THE FUNCTIONALIZATION OF NANOMATERIALS | ZYVEX PERFORMANCE MATERIALS, INC. (US) | 2009-08-13 | — | — | US | claimed |
| EP-1740655-A1 | METHODS FOR THE SYNTHESIS OF MODULAR POLY(PHENYLENEETHYNYLENES) AND FINE TUNING THE ELECTRONIC PROPERTIES THEREOF FOR THE FUNCTIONALIZATION OF NANOMATERIALS | Zyvex Corporation (US) | 2007-01-10 | — | — | EP | claimed |
| US-20060054866-A1 | Methods for the synthesis of modular poly(phenyleneethynlenes) and fine tuning the electronic properties thereof for the functionalization of nanomaterials | ZYVEX CORPORATION. (US) | 2006-03-16 | — | — | US | claimed |
| WO-2005100466-A1 | METHODS FOR THE SYNTHESIS OF MODULAR POLY(PHENYLENEETHYNYLENES) AND FINE TUNING THE ELECTRONIC PROPERTIES THEREOF FOR THE FUNCTIONALIZATION OF NANOMATERIALS | ZYVEX CORPORATION (US) | 2005-10-27 | — | — | WO | claimed |
| US-11680053-B2 | Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators | HEPTARES THERAPEUTICS LIMITED (GB) | 2023-06-20 | — | — | US | disclosed |
| US-11673100-B2 | Systems and methods for integrated solar photodialysis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-06-13 | — | — | US | disclosed |
| US-11673100-B2 | Systems and methods for integrated solar photodialysis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-06-13 | — | — | US | disclosed |
| US-11584732-B2 | Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators | HEPTARES THERAPEUTICS LIMITED (GB) | 2023-02-21 | — | — | US | disclosed |
| US-11318424-B2 | Light-driven ion-pumping membrane systems | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-05-03 | — | — | US | disclosed |
| EP-2854948-B1 | METAL-BASED THIOPHENE PHOTODYNAMIC COMPOUNDS AND THEIR USE | MCFARLAND SHERRI ANN (CA) | 2019-09-25 | — | — | EP | disclosed |
| US-20190217255-A1 | SYSTEMS AND METHODS FOR INTEGRATED SOLAR PHOTODIALYSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-07-18 | — | — | US | disclosed |
| WO-2005100466-A1 | METHODS FOR THE SYNTHESIS OF MODULAR POLY(PHENYLENEETHYNYLENES) AND FINE TUNING THE ELECTRONIC PROPERTIES THEREOF FOR THE FUNCTIONALIZATION OF NANOMATERIALS | ZYVEX CORPORATION (US) | 2005-10-27 | — | — | WO | disclosed |
| EP-0994834-A4 | LIGATED PLATINUM GROUP METAL CATALYST COMPLEX AND IMPROVED PROCESS FOR CATALYTICALLY CONVERTING ALKANES TO ESTERS AND DERIVATIVES THEREOF | CATALYTICA INC (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2004106420-A2 | NANOCOMPOSITES AND METHOD FOR PRODUCTION | ZYVEX CORPORATION (US) | 2004-12-09 | — | — | WO | disclosed |
| US-20030120125-A1 | Ligated platinum group metal catalyst complex and improved process for catalytically converting alkanes to esters and derivatives thereof | PERIANA ROY A (US) | 2003-06-26 | — | — | US | disclosed |
| EP-0994834-A1 | LIGATED PLATINUM GROUP METAL CATALYST COMPLEX AND IMPROVED PROCESS FOR CATALYTICALLY CONVERTING ALKANES TO ESTERS AND DERIVATIVES THEREOF | CATALYTICA, INC. (US) | 2000-04-26 | — | — | EP | disclosed |
| WO-1998050333-A1 | LIGATED PLATINUM GROUP METAL CATALYST COMPLEX AND IMPROVED PROCESS FOR CATALYTICALLY CONVERTING ALKANES TO ESTERS AND DERIVATIVES THEREOF | CATALYTICA, INC. (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1995005670-A1 | PHOTOVOLTAIC CELL WITH A PHOTO-SENSITISED, SEMICONDUCTING METAL OXIDE COATING | QUINTEN WERNER (DE) | 1995-02-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11680053-B2 | Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators | GRM5, GRM2, GRM6 | HSP90AA1 2558/4885CYP2D6 940/4885GRM5 1/4885 |
| US-11584732-B2 | Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators | GRM5, GRM2, GRM6 | HSP90AA1 2558/4885CYP2D6 940/4885GRM5 1/4885 |
| US-20030120125-A1 | Ligated platinum group metal catalyst complex and improved process for catalytically converting alkanes to esters and derivatives thereof | BID, MDH2, LIG4 | HSP90AA1 4553/4885CYP2D6 941/4885GRM5 873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.